Glimisave MV 1.3 Tablet SR
By Glimisave MV
Rx
10 Tablet SR in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Voglibose(0.3mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
June, 2027
About Glimisave MV 1.3 Tablet SR
Glimisave MV 1.3 Tablet SR is a medication classified as an anti-diabetic drug. It is a combination of Glimepiride, Metformin, and Voglibose, designed to help manage type 2 diabetes mellitus in adults when other treatments are not enough to control blood sugar levels effectively.
To benefit the most from Glimisave MV 1.3 Tablet SR, it should be taken regularly with food at the same time each day. Your doctor will determine the appropriate dosage based on your individual needs and may adjust it according to your blood sugar levels over time.
It's essential to continue taking Glimisave MV 1.3 Tablet SR as prescribed, even if you feel well or your blood sugar seems controlled. Abruptly stopping the medication without consulting your doctor can lead to increased blood sugar levels, posing risks of kidney damage, vision problems, nerve issues, and limb complications. Remember, this medication forms only a part of an overall treatment plan, which should also include a healthy diet, regular physical activity, and weight management as advised by your healthcare provider. Lifestyle modifications are crucial in managing diabetes effectively.
One of the primary side effects associated with Glimisave MV 1.3 Tablet SR is the risk of low blood glucose levels (hypoglycemia). It is important to be aware of the symptoms of hypoglycemia, such as sweating, dizziness, headaches, and shaking, and to know how to manage it. Maintaining regular meals and carrying a source of fast-acting glucose, such as sugary foods or fruit juice, can help prevent this condition. Avoiding alcohol consumption is also recommended, as it can increase the risk of low blood sugar levels. Additionally, other potential side effects that may occur include changes in taste perception, nausea, diarrhea, stomach discomfort, headaches, swelling, blurred vision, fractures, and respiratory infections. Some individuals may experience weight gain while taking this medication.
Individuals with type 1 diabetes, diabetic ketoacidosis, severe kidney or liver problems, or a history of heart disease should not use Glimisave MV 1.3 Tablet SR. Before starting this medication, inform your doctor about any conditions you have had, such as heart issues, and if you are pregnant or breastfeeding. Regular monitoring of blood sugar levels and additional blood tests may be necessary to track your progress while taking this medication.
It's important to consult a healthcare professional if you experience any side effects, especially if they worsen.
Benefits
Glimisave MV 1.3 Tablet SR is a beneficial medication for individuals with Type 2 diabetes mellitus. This medicine is essential in controlling high blood glucose levels, reducing the risk of serious complications associated with diabetes, such as kidney damage, eye damage, nerve problems, and loss of limbs. By slowing down the breakdown of food in the intestine to simple glucose and facilitating the removal of extra glucose through urine, Glimisave MV 1.3 Tablet SR helps in maintaining stable blood glucose levels after meals.
Moreover, consistent use of Glimisave MV 1.3 Tablet SR alongside a balanced diet and regular exercise can enhance the overall quality of life and promote cardiovascular health. Particularly for individuals with Type 2 diabetes and existing cardiovascular disease, this medication can lower the risk of mortality. Therefore, it is crucial to adhere to the prescribed dosage and duration of Glimisave MV 1.3 Tablet SR to safeguard and improve your future health. By incorporating Glimisave MV 1.3 Tablet SR into your diabetes management routine, you are taking essential steps towards a healthier and more fulfilling life.
How to use the Glimisave MV 1.3 Tablet SR
To use Glimisave MV 1.3 Tablet SR properly, follow the instructions given by your doctor regarding the dosage and duration of treatment. Take the tablet whole without chewing, crushing, or breaking it. It is important to take Glimisave MV 1.3 Tablet SR on an empty stomach for best results. Remember to swallow the tablet with water. If you have any questions or concerns about how to use this medication, consult your doctor for further guidance.
Uses of Glimisave MV 1.3 Tablet SR
The Glimisave MV 1.3 Tablet SR is primarily used for the treatment of Type 2 diabetes mellitus. This medication is specifically designed to help manage blood sugar levels in individuals with this condition. By taking this tablet as prescribed, patients can better control their diabetes and reduce the risk of complications associated with high blood sugar. It is important to follow the advice of healthcare professionals when using Glimisave MV 1.3 Tablet SR to ensure effective management of Type 2 diabetes mellitus.
What conditions Glimisave MV 1.3 Tablet SR treats?
Glimisave MV 1.3 Tablet SR is used to treat type 2 diabetes mellitus in adults by helping to control high blood sugar levels. It is important to take this medicine regularly and as prescribed by your doctor to prevent complications such as kidney damage, blindness, nerve problems, and loss of limbs associated with uncontrolled diabetes. Along with medication, maintaining a healthy lifestyle with a balanced diet, regular exercise, and weight management is crucial in managing diabetes. It is essential to be aware of and manage potential side effects like low blood glucose levels and seek medical advice if needed.
Should you consult a doctor?
If you experience persistent side effects of Glimisave MV 1.3 Tablet SR such as nausea, diarrhea, abdominal pain, or low blood sugar levels, seek medical attention. It is important to consult your doctor if these side effects continue or if you are concerned about them. Additionally, if you have symptoms of low blood glucose levels like sweating, dizziness, headache, or shaking, it is crucial to contact your healthcare provider. Moreover, if you have type 1 diabetes, diabetic ketoacidosis, severe kidney or liver disease, heart disease history, or if you are pregnant or breastfeeding, consult your doctor before taking this medication. Regular monitoring of blood sugar levels and consultation with your healthcare provider is recommended to ensure the safe and effective use of Glimisave MV 1.3 Tablet SR.
Side effects of Glimisave MV 1.3 Tablet SR
When taking Glimisave MV 1.3 Tablet SR, some common side effects may occur. These side effects are usually mild and may go away as your body gets used to the medication. However, if you experience any persistent or concerning side effects, it is important to consult your doctor. Possible side effects may include nausea, diarrhea, abdominal pain, hypoglycemia (low blood glucose level), and loss of appetite. If you notice any of these side effects and they are bothersome or worsen over time, seek medical advice.
Safety advice

liver
Glimisave MV 1.3 Tablet SR needs to be used carefully in individuals with liver disease. It may require adjustments in the dosage, so it is important to seek advice from a healthcare professional. Typically, Glimisave MV 1.3 Tablet SR is initiated at a low dose for patients with mild to moderate liver issues. However, this medication is not advisable for individuals with severe liver disease.

kidney
Glimisave MV 1.3 Tablet SR is not safe for patients with kidney disease and is not recommended for those with severe kidney issues. Please consult your doctor before using this medication.

alcohol
It is not safe to consume alcohol while taking Glimisave MV 1.3 Tablet SR.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Glimisave MV 1.3 Tablet SR. Your ability to drive may be impaired in such cases.

pregnancy
Glimisave MV 1.3 Tablet SR may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor for a thorough assessment of benefits and risks.

breastfeeding
Glimisave MV 1.3 Tablet SR is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Consumption warning before consuming Glimisave MV 1.3 Tablet SR
Before consuming Glimisave MV 1.3 Tablet SR, ensure to take it with food at the same time daily as prescribed by your doctor. Do not stop taking the medication without consulting your doctor, as it may lead to increased blood sugar levels, risking kidney damage, blindness, nerve problems, and limb loss. Remember, Glimisave MV 1.3 Tablet SR is just one part of your treatment plan, which should also include a healthy diet, exercise, and weight management as per your doctor's advice. It's crucial to recognize and manage symptoms of low blood glucose, such as sweating, dizziness, and shaking, by always carrying a fast-acting glucose source. Avoid alcohol consumption to prevent low blood sugar levels. Possible side effects of Glimisave MV 1.3 Tablet SR include taste changes, nausea, diarrhea, headaches, and weight gain. Consult your doctor before taking if you have certain medical conditions or if you are pregnant or breastfeeding. Regular monitoring of blood sugar levels and necessary tests are essential.
What if you forgot to take Glimisave MV 1.3 Tablet SR?
If you forget to take a dose of Glimisave MV 1.3 Tablet SR, try to take it as soon as you remember. But if it's almost time for your next dose, just skip the missed one and continue with your usual dosing schedule. Avoid taking a double dose to make up for the missed one. It's important to maintain consistency with your medication schedule to ensure the best results.
Related lab tests
When taking 'Glimisave MV 1.3 Tablet SR', it is important to monitor your blood sugar levels regularly through specific lab tests. These tests help in assessing how well the medication is managing your blood sugar levels. The related lab tests to consider are Fasting Blood Glucose, Postprandial Blood Glucose, and Glycosylated Hemoglobin. The Fasting Blood Glucose test measures your blood sugar after fasting for at least 8 hours, providing information about your baseline sugar levels. The Postprandial Blood Glucose test measures your blood sugar levels 2 hours after a meal, helping to evaluate how your body processes sugar after eating. Lastly, the Glycosylated Hemoglobin test reflects your average blood sugar levels over the past 2 to 3 months, giving a broader picture of your long-term sugar control. Monitoring these lab tests regularly can help you and your healthcare provider adjust the treatment plan effectively for better management of your condition.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹169.3
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024